News September 2, 2025 Soricimed Biopharma Inc. Strengthens Executive Team with Appointment of Dr. Michael Groaning PhD, as Chief Scientific Officer
News December 17, 2020 Soricimed to Investigate the Potential Benefit of SOR-C13 in the Treatment of COVID-19
News September 29, 2020 Soricimed Continues Critical Research Thanks to Support from the Government of Canada
News November 26, 2019 Soricimed Announces Journal of Cancer Publication Identifying TRPV6 as a Promising Target for Cancer Therapy
| 
| 
| 